News | June 29, 2024
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Signs MoUs with Shri Krishna Ayush University and Dabur India
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
Combined entity is better positioned to compete in increasingly competitive generics industry
The company will now explore a buyer for its manufacturing site and exit in due course
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Subscribe To Our Newsletter & Stay Updated
